Clene, Inc. (CLNN)
4.05
-0.23
(-5.37%)
USD |
NASDAQ |
Sep 01, 15:42
Clene Cash from Operations (Annual) : -18.55M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -18.55M |
| December 31, 2024 | -21.33M |
| December 31, 2023 | -30.17M |
| December 31, 2022 | -39.01M |
| December 31, 2021 | -34.62M |
| Date | Value |
|---|---|
| December 31, 2020 | -18.93M |
| December 31, 2019 | -13.20M |
| December 31, 2018 | -0.2054M |
| December 31, 2017 | -0.0024M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| NovelStem International Corp. | -0.1676M |
| Brainstorm Cell Therapeutics, Inc. | -6.975M |
| Summit Therapeutics, Inc. | -322.93M |
| Kezar Life Sciences, Inc. | -51.78M |
| Protara Therapeutics, Inc. | -56.36M |